Gene · 8454
Papers4,328
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,328
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of EZH2 protein stability: new mechanisms, roles in tumorigenesis, and roads to the clinic. | EBioMedicine | 2024 | 38244292 | PubTator, text mining | PubMed |
| The association of RBX1 and BAMBI gene expression with oocyte maturation in PCOS women. | BMC Med Genomics | 2024 | 38238750 | PubTator, text mining | PubMed |
| An update of predictive biomarkers related to WEE1 inhibition in cancer therapy. | J Cancer Res Clin Oncol | 2024 | 38231277 | PubTator, text mining | PubMed |
| The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer. | J Virol | 2024 | 38226814 | PubTator, text mining | PubMed |
| The phosphatase DUSP22 inhibits UBR2-mediated K63-ubiquitination and activation of Lck downstream of TCR signalling. | Nat Commun | 2024 | 38225265 | Swiss-Prot, curated | PubMed |
| Neddylation is a novel therapeutic target for lupus by regulating double negative T cell homeostasis. | Signal Transduct Target Ther | 2024 | 38221551 | PubTator, text mining | PubMed |
| Diabetic sensory neuropathy and insulin resistance are induced by loss of UCHL1 in Drosophila. | Nat Commun | 2024 | 38212312 | PubTator, text mining | PubMed |
| Deciphering the role of neddylation in tumor microenvironment modulation: common outcome of multiple signaling pathways. | Biomark Res | 2024 | 38191508 | PubTator, text mining | PubMed |
| CAND1 inhibits Cullin-2-RING ubiquitin ligases for enhanced substrate specificity. | Nat Struct Mol Biol | 2024 | 38177676 | PubTator, text mining | PubMed |
| Non-canonical non-genomic morphogen signaling in anucleate platelets: a critical determinant of prothrombotic function in circulation. | Cell Commun Signal | 2024 | 38172855 | PubTator, text mining | PubMed |
| NNMT/1-MNA Promote Cell-Cycle Progression of Breast Cancer by Targeting UBC12/Cullin-1-Mediated Degradation of P27 Proteins. | Adv Sci (Weinh) | 2024 | 38126621 | PubTator, text mining | PubMed |
| hGRAD: A versatile "one-fits-all" system to acutely deplete RNA binding proteins from condensates. | J Cell Biol | 2024 | 38108808 | PubTator, text mining | PubMed |
| Detecting and dissecting signaling crosstalk via the multilayer network integration of signaling and regulatory interactions. | Nucleic Acids Res | 2024 | 37953325 | PubTator, text mining | PubMed |
| Excessive BNIP3- and BNIP3L-dependent mitophagy underlies the pathogenesis of FBXL4-mutated mitochondrial DNA depletion syndrome. | Autophagy | 2024 | 37876279 | PubTator, text mining | PubMed |
| Succinylation modification: a potential therapeutic target in stroke. | Neural Regen Res | 2024 | 37843212 | PubTator, text mining | PubMed |
| Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer. | Breast Cancer | 2024 | 37812303 | PubTator, text mining | PubMed |
| A sporadic Parkinson's disease model via silencing of the ubiquitin-proteasome/E3 ligase component, SKP1A. | J Neural Transm (Vienna) | 2024 | 37644186 | PubTator, text mining | PubMed |
| Canonical and noncanonical Wnt signaling: Multilayered mediators, signaling mechanisms and major signaling crosstalk. | Genes Dis | 2024 | 37588235 | PubTator, text mining | PubMed |
| AZD7762 induces CRBN dependent BAG3 degradation through ubiquitin-proteasome pathway. | Anticancer Drugs | 2024 | 37449977 | PubTator, text mining | PubMed |
| Recent advances in targeted protein degraders as potential therapeutic agents. | Mol Divers | 2024 | 36790583 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8454/papers?page=10